Labarai

  • 2021 FDA Sabbin Magunguna 1Q-3Q

    Kirkiro yana haifar da ci gaba. Idan ya zo ga ƙira a cikin haɓaka sabbin magunguna da samfuran ilimin halittu masu warkarwa, Cibiyar Nazarin Magunguna da Bincike ta FDA (CDER) tana tallafawa masana'antar magunguna a kowane mataki na aiwatarwa. Tare da fahimtar ta ...
    Kara karantawa
  • Recent developments of Sugammadex Sodium in the wake period of anesthesia

    Abubuwan da ke faruwa na kwanan nan na Sugammadex Sodium a lokacin farkawa

    Sugammadex Sodium sabon ɗan adawa ne na zaɓaɓɓen murɗaɗɗen murɗaɗɗen tsoka (myorelaxants), wanda aka fara ba da rahotonsa a cikin mutane a 2005 kuma tun daga lokacin aka fara amfani da shi a asibiti a Turai, Amurka da Japan. Idan aka kwatanta da magungunan antiholinesterase na gargajiya ...
    Kara karantawa
  • Which tumors are thalidomide effective in treating!

    Waɗanne ciwace -ciwacen ne thalidomide masu tasiri a cikin jiyya!

    Thalidomide yana da tasiri wajen magance waɗannan ciwace -ciwacen! 1. A cikin abin da m tumor za a iya amfani da thalidomide. 1.1. ciwon huhu. 1.2. Ciwon daji na prostate. 1.3. nodal rectal cancer. 1.4. ciwon hanta hepatocellular. 1.5. Ciwon daji na ciki. ...
    Kara karantawa
  • Tofacitinib Citrate

    Tofacitinib Citrate

    Tofacitinib citrate magani ne na likitanci (sunan kasuwanci Xeljanz) wanda Pfizer ya kirkira don aji na masu hana Janus kinase (JAK). Zai iya zaɓar hana JAK kinase, toshe hanyoyin JAK/STAT, kuma ta hakan yana hana jujjuyawar siginar tantanin halitta da kuma bayanin jigon da ke da alaƙa da kunnawa ...
    Kara karantawa
  • Apixaban and Rivaroxaban

    Apixaban da Rivaroxaban foda

    A cikin 'yan shekarun nan, tallace -tallace na apixaban ya haɓaka cikin sauri, kuma kasuwar duniya ta riga ta wuce rivaroxaban. Saboda Eliquis (apixaban) yana da fa'ida akan warfarin wajen hana bugun jini da zubar jini, kuma Xarelto (Rivaroxaban) kawai ya nuna rashin kaskanci. Bugu da kari, Apixaban baya ...
    Kara karantawa
  • Guangzhou API exhibition in 2021

    Nunin API na Guangzhou a 2021

    Kayayyakin Kayayyakin Kayayyakin Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan lambu na Kan Najeje NajeECECE '' '' '(China (China) 86th International International Pharmaceutical Raw Materials/Intermediates/Packaging/Equipment Fair (API China a takaice) Oganeza: Reed Sinopharm Nunin Co., Ltd. Lokacin baje kolin: 26-28 ga Mayu, 2021 Wuri: Gidan shigo da fitarwa na kasar Sin (Guangzhou) Nunin sikelin: 60,000 murabba'in mita Ex ...
    Kara karantawa
  • Abubuwa masu guba

    A ranar 29 ga Yuni, Intercept Pharmaceuticals ta ba da sanarwar cewa ta karɓi cikakken sabon aikace-aikacen magunguna daga FDA ta Amurka game da FXR agonist obeticholic acid (OCA) don fibrosis da wasiƙar Amsar steatohepatitis (NASH) (CRL) ta haifar. FDA ta bayyana a cikin CRL cewa dangane da bayanan ...
    Kara karantawa
  • Remdesivir

    A ranar 22 ga Oktoba, lokacin Gabas, FDA ta Amurka a hukumance ta amince da Veklury (remdesivir) na Gileyad don amfani a cikin tsofaffi masu shekaru 12 da haihuwa kuma suna auna aƙalla kilogram 40 da ke buƙatar asibiti da magani na COVID-19. A cewar FDA, Veklury a halin yanzu shine kawai FDA ta amince da COVID-19 t ...
    Kara karantawa
  • Sanarwar amincewa da Rosuvastatin Calcium

    Kwanan nan, Nantong Chanyoo ya sake yin wani babban tarihi a cikin tarihi! Tare da ƙoƙarin sama da shekara ɗaya, MFDS ta karɓi KDMF na Chanyoo na farko. A matsayin babbar masana'anta na Rosuvastatin Calcium a China, muna fatan buɗe sabon babin a kasuwar Koriya. Kuma ƙarin samfuran za su b ...
    Kara karantawa
  • Registration Certificate (Rosuvastatin)

    Takaddar Rijista (Rosuvastatin)

    Kara karantawa
  • Bambanci tsakanin Ticagrelor da Clopidogrel

    Clopidogrel da Ticagrelor sune masu adawa da mai karɓar P2Y12 waɗanda ke hana adenosine diphosphate platelet (ADP) ta zaɓin hana ɗaurin adenosine diphosphate (ADP) zuwa farantin P2Y12 na farantin karfe da kuma aikin rukunin glycoprotein GPII.b/III.a na biyu. Bot ...
    Kara karantawa
  • Bambanci tsakanin allunan alli na atorvastatin da allunan allurar rosuvastatin

    Allunan allurar Atorvastatin da allunan rosuvastatin allunan magungunan rage yawan lipid ne, kuma duka suna cikin magungunan statin masu ƙarfi. Bambance-banbance na musamman sune kamar haka: 1. Daga mahangar magunguna, idan kashi ɗaya ne, tasirin ragewar lipid na rosu ...
    Kara karantawa
12 Gaba> >> Shafin 1 /2